Skip to main content

Table 1 Characteristics of the study population according to the new GDM IADPSG criteria and the old GDM WHO criteria

From: Low circulating pentraxin 3 levels in pregnancy is associated with gestational diabetes and increased apoB/apoA ratio: a 5-year follow-up study

Variable

Visit 3 (week 30–32) in the index pregnancy

Follow-up visit

GDM

Non-GDM

GDM

Non-GDM

N=

IADPSG

50

234

50

234

WHO

31

253

31

253

Follow-up time (years)

IADPSG

  

5.1 (4.6, 5.3)

4.8 (4.4, 5.4)

WHO

  

5.0 (4.5, 5.4)

4.8 (4.4, 5.4)

Age (years)a

IADPSG

33.6 ± 4.3

32.0 ± 3.7*

38.9 ± 4.4

37.4 ± 3.7*

WHO

33.1 ± 3.7

32.2 ± 3.8

38.6 ± 3.8

37.5 ± 3.8

Height (cm)a

IADPSG

169 ± 6

169 ± 6

168 ± 6

169 ± 6

WHO

168 ± 5

169 ± 6

168 ± 5

169 ± 6

BMI (kg/m2)

IADPSG

28.2 (26.8, 30.8)

26.2 (23.7, 28.4)**

24.7 (22.5, 28.0)

22.6 (20.8, 24.6)**

WHO

27.8 (25.7, 31.2)

26.4 (23.9, 28.6)

24.1 (21.7, 28.1)

22.8 (20.9, 25.1)*

Primipara n (%)

IADPSG

22 (44.0)

118 (51.1)

6 (12.0)

26 (11.1)

WHO

18 (60.0)

122 (48.6)

6 (19.3)

26 (10.3)

Family history heart disease n (%)

IADPSG

  

31 (64.5)

134 (57.7)

WHO

  

22 (75.9)

143 (57.0)

Family history diabetes n (%)

IADPSG

  

17 (34.0)

71 (30.3)

WHO

  

13 (41.9)

75 (29.6)

Currently smoking n (%)

IADPSG

1 (2.0)

7 (3.0)

13 (26.0)

35 (15.0)*

WHO

1 (3.2)

7 (2.8)

9 (29.0)

39 (15.4)*

Previous smoker n (%)

IADPSG

14 (28.0)

39 (16.7)

15 (30.0)

50 (21.3)

WHO

8 (25.8)

45 (17.8)

8 (25.8)

57 (22.5)

Systolic blood pressure (mmHg)

IADPSG

115 (105, 120)

110 (105, 120)

110 (100, 130)

110 (100, 120)

WHO

110 (100, 120)

110 (105, 120)

110 (100, 130)

110 (100, 120)

Diastolic blood pressure (mmHg)

IADPSG

70 (60,73)

70 (60, 70)

70 (65, 75)

70 (60, 75)

WHO

70 (60, 70)

70 (60, 70)

70 (65, 80)

70 (60, 75)

Mean arterial pressure (mmHg)

IADPSG

83.3 (78.3, 88.3)

81.7 (76.7, 86.7)

83.3 (76.7, 92.1)

83.3 (76.7,88,3)

WHO

82.5 (77.5, 86.7)

83.3 (76.7, 86.7)

83.3 (78.7, 95.0)

83.3 (76.7, 88.3)

Pulse pressure (mmHg)

IADPSG

45 (40,50)

43 (40,50)

40 (40,50)

40 (40,50)

WHO

40 (40,50)

45 (40,50)

40 (35,50)

40 (40,50)

  1. aVisit 1. Data given as mean ± SD when normal distributed and median (25th, 75th) when skewed distributed. Comparison between women with GDM and non-GDM were performed using t test for normal distributed variables, Mann–Whitney U for non-distributed continuous variables, and Chi test for categorical variables
  2. * p < 0.05
  3. ** p < 0.001
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840